UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.094

Sortiert nach

Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function

Clinical pharmacology in drug development, 2021-01, Vol.10 (1), p.68-77

2021

Volltextzugriff (PDF)

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction

Scientific reports, 2018-08, Vol.8 (1), p.11874-11, Article 11874

2018

Volltextzugriff (PDF)

Oral absorption of voriconazole is affected by SLCO2B1 c.396T>C genetic polymorphism in CYP2C19 poor metabolizers

The pharmacogenomics journal, 2020-12, Vol.20 (6), p.792-800

2020

Volltextzugriff (PDF)

Two-level inhibition of galK expression by Spot 42: Degradation of mRNA mK2 and enhanced transcription termination before the galK gene

Proceedings of the National Academy of Sciences - PNAS, 2015-06, Vol.112 (24), p.7581-7586

2015

Volltextzugriff (PDF)

Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects

Clinical and translational science, 2021-09, Vol.14 (5), p.1955-1966

2021

Volltextzugriff (PDF)

Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men

Frontiers in cellular and infection microbiology, 2021-05, Vol.11, p.629438-629438

2021

Volltextzugriff (PDF)

Impact of Vancomycin‐Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin

Clinical and translational science, 2020-07, Vol.13 (4), p.752-760

2020

Volltextzugriff (PDF)

Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis

Metabolites, 2020-04, Vol.10 (4), p.169

2020

Volltextzugriff (PDF)

The CnuK9E H-NS complex antagonizes DNA binding of DicA and leads to temperature-dependent filamentous growth in E. coli

PloS one, 2012-09, Vol.7 (9), p.e45236

2012

Volltextzugriff (PDF)

Establishment of an mRNA Gradient Depends on the Promoter: An Investigation of Polarity in Gene Expression

Journal of molecular biology, 2008-04, Vol.378 (2), p.318-327

2008

Volltextzugriff (PDF)

In vivo transcription dynamics of the galactose operon: a study on the promoter transition from P1 to P2 at onset of stationary phase

PloS one, 2011-03, Vol.6 (3), p.e17646-e17646

2011

Volltextzugriff (PDF)

Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole

Clinical pharmacokinetics, 2023-04, Vol.62 (4), p.599-608

2023

Volltextzugriff (PDF)

Featured Cover

Alimentary pharmacology & therapeutics, 2023-04, Vol.57 (7), p.i-i

2023

Volltextzugriff (PDF)

Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects

Alimentary pharmacology & therapeutics, 2020-12, Vol.52 (11-12), p.1640-1647

2020

Volltextzugriff (PDF)

Quantification of the galactose-operon mRNAs 5 bases different in their 5`-ends

BMB reports, 2010-07, Vol.43 (7), p.474-479

2010

Volltextzugriff (PDF)

Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects

Alimentary pharmacology & therapeutics, 2023-04, Vol.57 (7), p.763-772

2023

Volltextzugriff (PDF)

Cnu, a Novel oriC-Binding Protein of Escherichia coli

Journal of Bacteriology, 2005-10, Vol.187 (20), p.6998-7008

2005

Volltextzugriff (PDF)

Oral absorption of voriconazole is affected by SLCO2B1 c.396TC genetic polymorphism in CYP2C19 poor metabolizers

The pharmacogenomics journal, 2020-12, Vol.20 (6), p.792

2020

Volltextzugriff (PDF)

Quantification of the galactose-operon mRNAs 5 bases different in their 5'-ends

BMB Reports, 2010, 43(7), , pp.474-479

2010

Volltextzugriff (PDF)

Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways

Metabolomics, 2019-03, Vol.15 (3), p.30-12, Article 30

2019

Volltextzugriff (PDF)

Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject

Translational and clinical pharmacology, 2022-12, Vol.30 (4), p.212-225

2022

Volltextzugriff (PDF)

Expression of Each Cistron in the gal Operon Can Be Regulated by Transcription Termination and Generation of a galK-Specific mRNA, mK2

Journal of bacteriology, 2014-07, Vol.196 (14), p.2598-2606

2014

Volltextzugriff (PDF)

Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population

Journal of clinical pharmacology, 2019-08, Vol.59 (8), p.1085-1092

2019

Volltextzugriff (PDF)

The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects

Drug metabolism and pharmacokinetics, 2021-02, Vol.36, p.100368, Article 100368

2021

Volltextzugriff (PDF)

Two-level inhibition ofgalKexpression by Spot 42: Degradation of mRNA mK2 and enhanced transcription termination before thegalKgene

Proceedings of the National Academy of Sciences - PNAS, 2015-06, Vol.112 (24), p.7581-7586

2015

Volltextzugriff (PDF)

1 – 25 von 1.094

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(978)
Mit Volltextzugriff
(1.050)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(633)
Life Sciences & Biomedicine
(493)
Humans
(253)
Male
(183)
Female
(167)
Middle Aged
(125)
Adult
(99)
Animals
(89)
Physical Sciences
(88)
Aged
(87)
Technology
(74)
Oncology
(73)
Biological And Medical Sciences
(67)
Chemistry
(67)
Original
(67)
Retrospective Studies
(59)
Pharmacology & Pharmacy
(55)
Cardiovascular System & Cardiology
(50)
Risk Factors
(49)
Science & Technology - Other Topics
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction

Oral absorption of voriconazole is affected by SLCO2B1 c.396T>C genetic polymorphism in CYP2C19 poor metabolizers

Two-level inhibition of galK expression by Spot 42: Degradation of mRNA mK2 and enhanced transcription termination before the galK gene

Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects

Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men

Impact of Vancomycin‐Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin

Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis

The CnuK9E H-NS complex antagonizes DNA binding of DicA and leads to temperature-dependent filamentous growth in E. coli

Establishment of an mRNA Gradient Depends on the Promoter: An Investigation of Polarity in Gene Expression

In vivo transcription dynamics of the galactose operon: a study on the promoter transition from P1 to P2 at onset of stationary phase

Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole

Featured Cover

Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects

Quantification of the galactose-operon mRNAs 5 bases different in their 5`-ends

Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects

Cnu, a Novel oriC-Binding Protein of Escherichia coli

Oral absorption of voriconazole is affected by SLCO2B1 c.396TC genetic polymorphism in CYP2C19 poor metabolizers

Quantification of the galactose-operon mRNAs 5 bases different in their 5'-ends

Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways

Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject

Expression of Each Cistron in the gal Operon Can Be Regulated by Transcription Termination and Generation of a galK-Specific mRNA, mK2

Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population

The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects

Two-level inhibition ofgalKexpression by Spot 42: Degradation of mRNA mK2 and enhanced transcription termination before thegalKgene

Suchergebnisse filtern